ClinicalTrials.govpublic full text
A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)
multiple sclerosis, relapsing-remitting, relapsing-remitting multiple sclerosis, rebif®, avonex®, interferon-beta-1a, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 850976
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.